Medline Inc. (MDLN) Drawdown History
5 recorded drawdown events with recovery analysis
Price
$43.88
All-Time High
$49.99
Current Drawdown
-12.2%
Severity Score
2.6
Zone
Moderately Elevated
Drawdown Distribution
How MDLN's 5 recorded drawdowns break down by severity:
2
< 5%
2
5-10%
1
10-20%
0
20-30%
0
30%+
Recovery Patterns
When MDLN drops 10% or more from its high, it has happened 1 times with an average duration of 28 days and an average maximum drop of -11.9%.
All Drawdown Events
Showing 3 events with drops of 5% or more, sorted by depth.
| # | Start Date | End Date | Max Drop | Duration | Start Price | Low Price |
|---|---|---|---|---|---|---|
| 1 | 2025-12-26 | 2026-01-22 | -11.9% | 28 days | $44.28 | $39.00 |
| 2 | 2026-02-10 | 2026-02-18 | -6.0% | 9 days | $47.37 | $44.55 |
| 3 | 2026-01-28 | 2026-02-06 | -5.6% | 10 days | $46.31 | $43.73 |
2 minor events (under 5% drop) not shown.
Frequently Asked Questions
What is MDLN's biggest all-time drawdown?
Medline Inc.'s deepest recorded drawdown was -11.9%, which occurred from 2025-12-26 to 2026-01-22 and lasted 28 days. The stock dropped from $44.28 to a low of $39.00.
How long does it take MDLN to recover from a drawdown?
When MDLN drops 10% or more from its high, it has historically recovered within an average of 28 days. This is based on 1 comparable events in the tracked history.
Is MDLN at an all-time high?
No, Medline Inc. is currently trading at $43.88, which is -12.2% below its all-time high of $49.99. The current Drawdown Severity Score is 2.6 (Moderately Elevated).
How many drawdown events has MDLN experienced?
Medline Inc. has experienced 5 tracked drawdown events. Of these, 3 were drops of 5% or more. The average maximum drawdown across all events is -5.9%.
Track MDLN's Severity Score
Set custom alerts for Medline Inc. and get notified when it crosses into new severity zones.
Get Started FreeDisclaimer: DrawdownAlerts provides historical data analysis, not financial advice. Past performance does not guarantee future results. Severity scores are analytical tools, not buy/sell signals. Always do your own research before making investment decisions.